NCT01776398View on ClinicalTrials.gov

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

August 29, 2012

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Chronic Obstructive Pulmonary Disease (COPD)SmokingSmoking CessationIdiopathic Pulmonary Fibrosis (IPF)Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD)Scleroderma-Associated Interstitial Lung Disease (SSC-ILD)
Trial Locations (1)

10065-4870

RECRUITING

Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Cystic Fibrosis Foundation

OTHER

lead

Weill Medical College of Cornell University

OTHER